Related Experiment Video
Updated: Apr 20, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
An update on IgG4-related disease
Zachary S Wallace1, John H Stone
1aFellow in Rheumatology Massachusetts General Hospital bProfessor of Medicine Harvard Medical School Director Clinical Rheumatology Massachusetts General Hospital.
Recent developments in IgG4-related disease (IgG4-RD) include new manifestations and diagnostic insights. Future research aims for noninvasive biomarkers and novel treatments beyond glucocorticoids for this fibroinflammatory condition.
Area of Science:
- Immunology
- Rheumatology
- Pathology
Background:
- Immunoglobulin G4-related disease (IgG4-RD) is a complex fibroinflammatory condition with multi-organ involvement.
- Understanding of IgG4-RD's clinical spectrum, pathogenesis, and therapeutic strategies is rapidly evolving.
Purpose of the Study:
- To review and highlight recent advancements in the understanding and management of IgG4-related disease.
- To discuss new disease manifestations, diagnostic approaches, and emerging research findings.
Main Methods:
- Literature review focusing on recent publications and research in IgG4-related disease.
- Synthesis of findings on clinical presentations, diagnostic biomarkers, histopathological features, and immunological aspects.
Main Results:
- Identification of novel clinical manifestations of IgG4-RD.
- Evaluation of serum IgG4 concentrations for diagnostic utility and recognition of limited specificity of IgG4+ plasma cells.
- Preliminary insights into unique B and T lymphocyte populations implicated in IgG4-RD pathogenesis.
Conclusions:
- Further research is needed to identify reliable noninvasive biomarkers for IgG4-RD diagnosis.
- Development of novel therapeutic agents is crucial to potentially replace or complement current glucocorticoid-based treatments.
Related Concept Videos
Huntington Disease l: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Activation and Inactivation of G Proteins
Graves Disease II: Pathophysiology
GPCRs Regulate Adenylyl Cylase Activity
Pleiotropy

